Susan S. Smyth

High Impact

Role not yet determined Is this you? Add your title

UAMS

Formerly Arkansas Affiliated with UAMS through 2024.

50 h-index 241 pubs 9,480 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Susan S. Smyth's research focuses on platelet function and its role in hemostasis and thrombosis. Her work investigates the molecular mechanisms underlying platelet activation and aggregation, including the involvement of specific proteins like Rap1b and glycoprotein IIb-IIIa. Smyth has studied platelet behavior in various contexts, such as embolic middle cerebral artery occlusion and the microvasculature. She has also contributed to understanding biomarkers of thrombotic risk, particularly in the context of COVID-19.

Her research group has been funded by the NIH for projects examining serum amyloid as a mediator between inflammation and thrombosis, and for investigating the role of lysophosphatidic acid in cardiovascular disease risk. Smyth has a publication record of 78 articles with 1,739 citations and an h-index of 20, indicating a significant contribution to her field. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Jerry Ware and Nishank Jain.

Metrics

h-index: 50
Publications: 241
Citations: 9,480

Selected Publications

Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides (2024)

Atherosclerosis 6 citations DOI OpenAlex
438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease (2023)

Journal of Clinical and Translational Science DOI OpenAlex
Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department (2023)

PEC Innovation 5 citations DOI OpenAlex
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023)

Vascular Pharmacology 12 citations DOI OpenAlex
Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death (2022)

Arteriosclerosis Thrombosis and Vascular Biology DOI OpenAlex
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study (2022)

Kidney360 13 citations DOI OpenAlex
Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death (2022)

International Journal of Molecular Sciences 17 citations DOI OpenAlex
Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center (2022)

Cardiology Research 4 citations DOI OpenAlex
Bioactive lipids and metabolic syndrome—a symposium report (2022)

Annals of the New York Academy of Sciences 12 citations DOI OpenAlex
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium (2022)

Nature Reviews Cardiology 296 citations DOI OpenAlex
KL2 scholars’ perceptions of factors contributing to sustained translational science career success (2021)

Journal of Clinical and Translational Science 17 citations DOI OpenAlex
Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool (2021)

Journal of Medical Internet Research 7 citations DOI OpenAlex
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles (2021)

Journal of Thrombosis and Thrombolysis 17 citations DOI OpenAlex